David Henry Mack - 20 Jul 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ David H. Mack
Issuer symbol
PMVP
Transactions as of
20 Jul 2021
Net transactions value
-$978,920
Form type
4
Filing time
22 Jul 2021, 16:24:13 UTC
Previous filing
29 Jun 2021
Next filing
20 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $545 +1,029 +8.3% $0.5300* 13,499 20 Jul 2021 Direct
transaction PMVP Common Stock Sale $36,560 -1,029 -7.6% $35.53 12,470 20 Jul 2021 Direct F1
transaction PMVP Common Stock Options Exercise $14,187 +26,767 +215% $0.5300* 39,237 21 Jul 2021 Direct
transaction PMVP Common Stock Sale $957,092 -26,767 -68% $35.76 12,470 21 Jul 2021 Direct F1, F2
holding PMVP Common Stock 227,915 20 Jul 2021 See footnote F3
holding PMVP Common Stock 56,978 20 Jul 2021 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 -1,029 -0.22% $0.000000 473,841 20 Jul 2021 Common Stock 1,029 $0.5300 Direct F5
transaction PMVP Stock Option (right to buy) Options Exercise $0 -26,767 -5.6% $0.000000 447,074 21 Jul 2021 Common Stock 26,767 $0.5300 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $36.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 The shares are held of record by The Mack-Mulligan Revocable Trust, for which the Reporting Person serves as co-trustee.
F4 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust, for which the Reporting Person serves as co-trustee.
F5 The shares subject to the option are fully vested and immediately exercisable.